The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Open accessAbstract
BACKGROUND: Vulvar intraepithelial neoplasia is a chronic disorder caused by high-risk types of human papillomavirus (HPV), most commonly HPV type 16 (HPV-16). Spontaneous regression occurs in less than 1.5% of patients, and the rate of recurrence after treatment is high. METHODS: We investigated the immunogenicity and efficacy of a synthetic long-peptide vaccine in women with HPV-16-positive, high-grade vulvar intraepithelial neoplasia. Twenty women with HPV-16-positive, grade 3 vulvar intraepithelial neoplasia were vaccinated three or four times with a mix of long peptides from the HPV-16 viral oncoproteins E6 and E7 in incomplete Freund's adjuvant. The end points were clinical and HPV-16-specific T-cell responses. RESULTS: The most common adverse events were local swelling in 100% of the patients and fever in 64% of the patients; none of these events exceeded grade 2 of the Common Terminology Criteria for Adverse Events of the National Cancer Institute. At 3 months after the last vaccination, 12 of 20 patients (60%; 95% confidence interval [CI], 36 to 81) had clinical responses and reported relief of symptoms. Five women had complete regression of the lesions, and HPV-16 was no longer detectable in four of them. At 12 months of follow-up, 15 of 19 patients had clinical responses (79%; 95% CI, 54 to 94), with a complete response in 9 of 19 patients (47%; 95% CI, 24 to 71). The complete-response rate was maintained at 24 months of follow-up. All patients had vaccine-induced T-cell responses, and post hoc analyses suggested that patients with a complete response at 3 months had a significantly stronger interferon-gamma-associated proliferative CD4+ T-cell response and a broad response of CD8+ interferon-gamma T cells than did patients without a complete response. CONCLUSIONS: Clinical responses in women with HPV-16-positive, grade 3 vulvar intraepithelial neoplasia can be achieved by vaccination with a synthetic long-peptide vaccine against the HPV-16 oncoproteins E6 and E7. Complete responses appear to be correlated with induction of HPV-16-specific immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
de Roda Husman, A.-M., Walboomers, J. M. M., van den Brule, A. J. C., Meijer, C. J. L. M., & Snijders, P. J. F. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-4-1057 · Cited by 1,283
Natural History of Cervical Intraepithelial Neoplasia: A Critical Review
Östör, A. G. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199304000-00018 · Cited by 1,260
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
Matloubian, M., Concepcion, R. J., & Ahmed, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8056-8063.1994 · Cited by 1,157
Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
Melief, C. J. M., & van der Burg, S. H. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2373 · Cited by 594
Self-citationvan den Brule, A. J. C., Pol, R., Fransen-Daalmeijer, N., Schouls, L. M., Meijer, C. J. L. M., & Snijders, P. J. F. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.779-787.2002 · Cited by 553
Zwaveling, S., Mota, S. C. F., Nouta, J., Johnson, M., Lipford, G. B., Offringa, R., van der Burg, S. H., & Melief, C. J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.350 · Cited by 417
Self-citationTreatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod
van Seters, M., van Beurden, M., ten Kate, F. J. W., Beckmann, I., Ewing, P. C., Eijkemans, M. J. C., Kagie, M. J., Meijer, C. J. M., Aaronson, N. K., KleinJan, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa072685 · Cited by 398
Welters, M. J. P., Kenter, G. G., Piersma, S. J., Vloon, A. P. G., Löwik, M. J. G., Berends-van der Meer, D. M. A., Drijfhout, J. W., Valentijn, A. R. P. M., Wafelman, A. R., Oostendorp, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1880 · Cited by 373
Self-citationA Population-Based Study of Squamous Cell Vaginal Cancer: HPV and Cofactors
Daling, J. R., Madeleine, M. M., Schwartz, S. M., Shera, K. A., Carter, J. J., McKnight, B., Porter, P. L., Galloway, D. A., McDougall, J. K., & Tamimi, H. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2001.6502 · Cited by 346
van Seters, M., van Beurden, M., & de Craen, A. J. M. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.02.012 · Cited by 338
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Löwik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Drijfhout, J. W., Wafelman, A. R., Oostendorp, J., Fleuren, G. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1881 · Cited by 315
Self-citationde Jong, A., van Poelgeest, M. I. E., van der Hulst, J. M., Drijfhout, J. W., Fleuren, G. J., Melief, C. J. M., Kenter, G., Offringa, R., & van der Burg, S. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0831 · Cited by 309
Self-citationVulvar Intraepithelial Neoplasia: Aspects of the Natural History and Outcome in 405 Women
Jones, R. W., Rowan, D. M., & Stewart, A. W. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187301.76283.7f · Cited by 273
Insinga, R. P., Liaw, K.-L., Johnson, L. G., & Madeleine, M. M. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2922 · Cited by 267
Srodon, M., Stoler, M. H., Baber, G. B., & Kurman, R. J. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213291.96401.48 · Cited by 213
Welters, M. J. P., de Jong, A., van den Eeden, S. J. F., van der Hulst, J. M., Kwappenberg, K. M. C., Hassane, S., Franken, K. L. M. C., Drijfhout, J. W., Fleuren, G. J., Kenter, G. G., et al. (2003) · PubMed · Cited by 213
Self-citationDetection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers
Tieben, L. M., Schegget, J. T., Minnaar, R., Bouwes Bavinck, J. N., Berkhout, R. J. M., Vermeer, B. J., Jebbink, M. F., & Smits, H. L. (1993) · Journal of Virological Methods · doi:10.1016/0166-0934(93)90038-s · Cited by 181
FRAZER, I., QUINN, M., NICKLIN, J., TAN, J., PERRIN, L., NG, P., OCONNOR, V, WHITE, O., WENDT, N., & MARTIN, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.05.013 · Cited by 176
Nakagawa, M., Stites, D. P., Patel, S., Farhat, S., Scott, M., Hills, N. K., Palefsky, J. M., & Moscicki, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315706 · Cited by 175
Baldwin, P., van der Burg, S. H., Boswell, C. M., Offringa, R., Hickling, J., Dobson, J., Roberts, J. S. C., Latimer, J. A., Moseley, R., Coleman, N., et al. (2003) · PubMed · Cited by 174
Self-citationCrosbie, E. J., Boswell, C. M., Sehr, P. A., Pawlita, M., Tomlinson, A., McVey, R. J., Dobson, J., Roberts, J. S. C., Hickling, J., Kitchener, H. C., et al. (2003) · PubMed · Cited by 172
Nakagawa, M., Stites, D. P., Farhat, S., Sisler, J. R., Moss, B., Kong, F., Moscicki, A., & Palefsky, J. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/513992 · Cited by 165
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.
de Jong, A., van der Burg, S. H., Kwappenberg, K. M. C., van der Hulst, J. M., Franken, K. L. M. C., Geluk, A., van Meijgaarden, K. E., Drijfhout, J. W., Kenter, G. G., Vermeij, P., et al. (2002) · PubMed · Cited by 156
Self-citationvan der Burg, S. H., Ressing, M. E., Kwappenberg, K. M. C., de Jong, A., Straathof, K. C. M., de Jong, J., Geluk, A., van Meijgaarden, K. E., Franken, K. L. M. C., Ottenhoff, T. H. M., et al. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1119>3.0.co;2-c · Cited by 153
Self-citationSmyth, L. J. C., van Poelgeest, M. I. E., Crosbie, E. J., Kwappenberg, K. M. C., Burt, D., Sehr, P. A., Pawlita, M., Man, S., Hickling, J., Fiander, A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0703 · Cited by 128
Self-citationZajac, A. J., Murali‐Krishna, K., Blattman, J. N., & Ahmed, R. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80119-2 · Cited by 124
Vambutas, A., DeVoti, J. A., Nouri, M., Drijfhout, J. W., Lipford, G. B., Bonagura, V. R., van der Burg, S. H., & Melief, C. J. M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.049 · Cited by 110
Self-citationvan Poelgeest, M. I. E., van Seters, M., van Beurden, M., Kwappenberg, K. M. C., Heijmans‐Antonissen, C., Drijfhout, J. W., Melief, C. J. M., Kenter, G. G., Helmerhorst, T. J. M., Offringa, R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0616 · Cited by 91
Self-citationvan Steenwijk, P. J. D. V., Piersma, S. J., Welters, M. J. P., van der Hulst, J. M., Fleuren, G. J., Hellebrekers, B. W. J., Kenter, G. G., & van der Burg, S. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0994 · Cited by 42
Self-citation
Cited by
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature · doi:10.1038/nature22991 · Cited by 2,936
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Metadata
- Authors
- Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., Wafelman, A. R., Oostendorp, J., Fleuren, G. J., van der Burg, S. H., & Melief, C. J. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-11-05
- Volume
- 361
- Issue
- 19
- Pages
- 1838-1847
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2096866753
- Cited by
- 1,102
- References
- 32
- FWCI
- 47.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.